Key Record Dates
ClinicalTrials.gov Identifier: | NCT03942887 |
---|---|
Brief Title: | Exploring Durable Remission With Rituximab in Antineutrophil Cytoplasmic Antibody(ANCA)-Associated Vasculitis (ENDURRANCE-1) |
First Submitted : | April 8, 2019 |
First Submitted that Met QC Criteria : | May 7, 2019 |
First Posted : | May 8, 2019 |
Last Update Submitted that Met QC Criteria : | May 16, 2022 |
Last Update Posted : | May 20, 2022 |